Skip to main content

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Q4 2025 vs. Q3 2025

How the institutions holding Esperion Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ESPR: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders1893201+15
Shares108.0M60.0K151.3M+43.4M (+40.2%)
Value$286.1M$159.0K$559.6M+$273.7M (+95.7%)

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (43)

Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to ESPR in Q4 2025
InstitutionSharesValue% of portfolio
OrbiMed Advisors LLC5,965,498$22.1M0.45%
Eversept Partners, LP3,851,133$14.2M0.80%
Velan Capital Investment Management LP1,210,000$4.48M2.60%
Burkehill Global Management, LP400,000$1.48M0.10%
Quadrature Capital Ltd259,563$960.4K0.01%
Virtus Investment Advisers, Inc.177,508$656.8K0.18%
XTX Topco Ltd161,974$599.3K0.02%
Polen Capital Management LLC116,292$430.3K0.00%
Round Rock Advisors, LLC101,553$375.7K0.06%
Schonfeld Strategic Advisors LLC75,238$278.4K0.00%
Integrated Quantitative Investments LLC72,249$267.3K0.06%
nVerses Capital, LLC67,450$249.6K0.56%
Lighthouse Investment Partners, LLC66,890$247.5K0.01%
State of Wyoming63,352$234.4K0.03%
Savvy Advisors, Inc.60,000$222.0K0.01%
Versor Investments LP51,800$191.7K0.03%
ACT Capital Management, LLC47,500$175.8K0.14%
ExodusPoint Capital Management, LP34,815$128.8K0.00%
Lazard Asset Management LLC33,741$124.8K0.00%
Scientech Research LLC29,846$110.4K0.07%
EntryPoint Capital, LLC23,500$87.0K0.03%
HSBC Holdings PLC18,510$69.5K0.00%
Hudson Bay Capital Management LP18,230$67.5K0.00%
CIBC World Markets Corp15,477$57.3K0.00%
Neuberger Berman Group LLC14,455$53.5K0.00%
Traynor Capital Management, Inc.14,386$53.2K0.00%
Acadian Asset Management LLC11,112$41.0K0.00%
Captrust Financial Advisors10,858$40.2K0.00%
Larson Financial Group LLC10,500$38.9K0.00%
Cary Street Partners Financial LLC10,175$37.6K0.00%
KFG Wealth Management, LLC10,000$37.0K0.00%
Kestra Advisory Services, LLC9,570$35.4K0.00%
Walleye Trading LLC3,863$14.3K0.00%
Laurel Wealth Advisors LLC2,500$9.25K0.00%
Federated Hermes, Inc.1,716$6.35K0.00%
Rockefeller Capital Management L.P.720$2.66K0.00%
GAMMA Investing LLC523$1.94K0.00%
Signaturefd, LLC442$1.64K0.00%
Cornerstone Financial Management LLC238$8810.00%
National Bank of Canada165$6100.00%
Farther Finance Advisors, LLC90$3330.00%
Sunbelt Securities, Inc.7$260.00%
True Wealth Design, LLC1$40.00%

Sold out (28)

Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (3)

Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ESPR in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Point72 (DIFC) Ltd31,989$84.8K
CIBC Bancorp USA Inc.21,286$56.4K
Point72 Europe (London) LLP6,719$17.8K